Literature DB >> 16625213

ICAM1 amino-acid variant K469E is associated with paediatric bronchial asthma and elevated sICAM1 levels.

B Puthothu1, M Krueger, M Bernhardt, A Heinzmann.   

Abstract

Intercellular adhesion molecule-1 (ICAM1) acts as ligand for beta2-integrin molecules and mediates leucocyte trafficking to the site of inflammation. Intercellular adhesion molecule-1-deficient mice show impaired lymphocyte recruitment to the lung, less airway hyper-responsiveness and less lung inflammation than healthy controls. Thus, the aim of the study was to test common ICAM1 polymorphisms for association with paediatric asthma. Furthermore, we were interested in whether soluble ICAM1 (sICAM1) serum levels were in correlation with genotypes. The following polymorphisms in ICAM1 were genotyped on 352 children with asthma and 270 controls: rs5491 (resulting in the amino-acid exchange K56M), rs5493 (G241S), rs5498 (K469E), rs5030400 (R478W) and rs885743 in the 3'-untranslated region. In addition, sICAM1 serum levels were measured. Only K469E and rs885743 were present in our populations. K469E showed association with asthma (P = 0.0037 with Armitage's trend test). Haplotype analysis by FAMHAP using both polymorphisms revealed association with asthma by P < 0.000001. In addition, serum sICAM1 levels were correlated with K469E genotypes (P = 0.009 by Kruskal-Wallis test). We conclude from our data that K469KE is associated with paediatric asthma in the German population. Furthermore, the same polymorphism is correlated with serum levels of sICAM1. Functional analyses have to further clarify the pathophysiological mechanism conferred by the polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16625213     DOI: 10.1038/sj.gene.6364302

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  16 in total

Review 1.  Pharmacogenomics and end-organ susceptibility to injury in the perioperative period.

Authors:  Debra A Schwinn; Mihai Podgoreanu
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2008-03

2.  Impacts of ICAM-1 gene polymorphisms on urothelial cell carcinoma susceptibility and clinicopathologic characteristics in Taiwan.

Authors:  Shian-Shiang Wang; Ming-Ju Hsieh; Yen-Chuan Ou; Chuan-Shu Chen; Jian-Ri Li; Pei-Ching Hsiao; Shun-Fa Yang
Journal:  Tumour Biol       Date:  2014-05-02

3.  Polymorphisms in the ICAM1 gene predict circulating soluble intercellular adhesion molecule-1(sICAM-1).

Authors:  Suzette J Bielinski; Alex P Reiner; Deborah Nickerson; Chris Carlson; Kent R Bailey; Bharat Thyagarajan; Leslie A Lange; Eric A Boerwinkle; David R Jacobs; Myron D Gross
Journal:  Atherosclerosis       Date:  2011-02-18       Impact factor: 5.162

4.  Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels.

Authors:  Maja Barbalic; Josée Dupuis; Abbas Dehghan; Joshua C Bis; Ron C Hoogeveen; Renate B Schnabel; Vijay Nambi; Monique Bretler; Nicholas L Smith; Annette Peters; Chen Lu; Russell P Tracy; Nena Aleksic; Jan Heeriga; John F Keaney; Kenneth Rice; Gregory Y H Lip; Ramachandran S Vasan; Nicole L Glazer; Martin G Larson; Andre G Uitterlinden; Jennifer Yamamoto; Peter Durda; Talin Haritunians; Bruce M Psaty; Eric Boerwinkle; Albert Hofman; Wolfgang Koenig; Nancy S Jenny; Jacqueline C Witteman; Christie Ballantyne; Emelia J Benjamin
Journal:  Hum Mol Genet       Date:  2010-02-18       Impact factor: 6.150

5.  On the use of variance per genotype as a tool to identify quantitative trait interaction effects: a report from the Women's Genome Health Study.

Authors:  Guillaume Paré; Nancy R Cook; Paul M Ridker; Daniel I Chasman
Journal:  PLoS Genet       Date:  2010-06-17       Impact factor: 5.917

6.  Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors influence susceptibility to coronary artery disease.

Authors:  Beata Sarecka-Hujar; Iwona Zak; Jolanta Krauze
Journal:  Clin Exp Med       Date:  2008-12-02       Impact factor: 3.984

7.  ICAM1 and VCAM1 polymorphisms, coronary artery calcium, and circulating levels of soluble ICAM-1: the multi-ethnic study of atherosclerosis (MESA).

Authors:  Suzette J Bielinski; James S Pankow; Na Li; Fang-Chi Hsu; Sara D Adar; Nancy Swords Jenny; Donald W Bowden; Bruce A Wasserman; Donna Arnett
Journal:  Atherosclerosis       Date:  2008-03-14       Impact factor: 5.162

8.  Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro.

Authors:  Shekar Srinivas; Jihong Dai; Joyce Eskdale; Grant E Gallagher; Nicholas J Megjugorac; Grant Gallagher
Journal:  Immunology       Date:  2008-06-10       Impact factor: 7.397

9.  Circulating soluble ICAM-1 levels shows linkage to ICAM gene cluster region on chromosome 19: the NHLBI Family Heart Study follow-up examination.

Authors:  Suzette J Bielinski; James S Pankow; Catherine Leiendecker Foster; Michael B Miller; Paul N Hopkins; John H Eckfeldt; Jim Hixson; Yongmei Liu; Tom Register; Richard H Myers; Donna K Arnett
Journal:  Atherosclerosis       Date:  2007-11-28       Impact factor: 5.162

10.  Genome-wide association analysis of soluble ICAM-1 concentration reveals novel associations at the NFKBIK, PNPLA3, RELA, and SH2B3 loci.

Authors:  Guillaume Paré; Paul M Ridker; Lynda Rose; Maja Barbalic; Josée Dupuis; Abbas Dehghan; Joshua C Bis; Emelia J Benjamin; Dov Shiffman; Alexander N Parker; Daniel I Chasman
Journal:  PLoS Genet       Date:  2011-04-21       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.